Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 260 of 6351
-
Balloon in the womb may ease lung pressure in severe birth defect
Disease control Recruiting nowCongenital diaphragmatic hernia (CDH) occurs when the diaphragm fails to fully fuse and leaves a portal through which abdominal structures can migrate into the thorax. In the more severe cases, the abdominal structures remain in the thoracic cavity and compromise the development …
Sponsor: Michael A Belfort • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could a simple blood injection reverse early menopause?
Disease control Recruiting nowAutologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve patients' hormonal profile in patients presenting with POI.
Phase 2/3 • Sponsor: Genesis Athens Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a One-Two punch of immune boosters revive cancer treatment?
Disease control Stopped earlyThe primary objective of this single arm phase 2 trial is to assess the response rate \[complete response (CR) + partial response (PR)\] of combined nivolumab and HD IL-2 in subjects with metastatic melanoma and renal cell carcinoma. Response will be performed after each course o…
Phase 2 • Sponsor: Gregory Daniels • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New combo aims to outsmart resistant lung cancer
Disease control CompletedThis study will compare the efficacy of the investigational agent sitravatinib in combination with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression on or after platinum-based chemotherapy and checkpoint in…
Phase 3 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Broccoli extract could slash psychosis risk in At-Risk youth
Prevention OngoingThis is a randomized, double-blind, placebo-controlled, multi-centre trial. A total of 300 CHR subjects will be identified in the course of face-to-face interviews using the Structured Interview for Prodromal Syndromes. All participants will be randomly allocated to SFN group (n …
Phase 3 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Can a drug duo rebuild bone in men better than one?
Disease control CompletedOsteoporotic fractures are a key health problem in older men. Although there are drugs approved to treat osteoporosis in men \[bisphosphonates, denosumab, and teriparatide (TPTD) or PTH(1-34)\], there is a lack of knowledge on how to use them effectively. TPTD is a potent bone an…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a cancer vaccine prime the body to better fight liver tumors?
Disease control OngoingThe prognosis of advanced hepatocellular carcinoma is poor. In this study, the eligible patients will be treated by tumor antigen-pulsed autologous dendritic cells and followed by TACE. The end points are to see tumor response and patient survival.
Phase 2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New oral drug shows promise for kids with rare RET-Driven cancers
Disease control OngoingThis is an open-label, multi-center Phase 1/2 study of oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET) alteration and an advanced solid or primary CNS tumor.
Phase 1/2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could everyday aspirin and statins fight advanced prostate cancer?
Disease control Recruiting nowThis is a 2x2 factorial randomized, multicenter, international, open phase III trial. The primary objective is to evaluate the benefit of acetylsalicylic acid and atorvastatin on overall survival (OS) (main endpoint) for patients with castrate-resistant prostate cancer starting …
Phase 3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug may keep High-Risk skin cancer from coming back
Disease control OngoingThe primary objective of the study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant cemiplimab, versus those treated with placebo, after surgery and radiation therapy (RT). The secondary objective…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Immunotherapy boosts bladder cancer treatment in major trial
Disease control OngoingThis phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such a…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Keytruda may keep liver cancer at bay after surgery
Disease control CompletedThis study will evaluate the safety and efficacy of pembrolizumab (MK-3475) versus placebo as adjuvant therapy in participants with hepatocellular carcinoma (HCC) and complete radiological response after surgical resection or local ablation. The primary hypotheses of this study a…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a Gene-Targeted pill turn the tide against a rare blood cancer?
Disease control Ongoingpatients with MDS (Myelodysplastic Syndrome) and mutated IDH1 patients will be treated with AG120 (IDH1 inhibitor)
Phase 2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a better scan sharpen radiation for prostate cancer?
Disease control OngoingThis phase II trial studies how well a positron emission tomography (PET)/computed tomography (CT) scan using fluciclovine F18 compared with a PET/CT scan with 68Ga-PSMA works in planning radiation treatments and enhancing outcomes in patients with prostate adenocarcinoma. Flucic…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Short steroid course after first wheeze may stop asthma before it starts
Prevention Recruiting nowThe overall objective of the study is to determine the efficacy of corticosteroids in preventing recurrent wheezing and asthma in high-risk, first-time severe wheezing children with rhinovirus infection, stratified by rhinovirus genome load. The secondary objectives are to deter…
Phase 4 • Sponsor: St. Olavs Hospital • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Can a modified vitamin a pill save sight in dry AMD?
Disease control CompletedThis is a double-masked, multicenter, randomized, placebo-controlled clinical trial, evaluating the efficacy and safety of ALK-001 in participants with Geographic Atrophy (GA) secondary to age-related macular degeneration (AMD). Up to 200 participants will receive ALK-001 while …
Phase 2/3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Heated chemotherapy during surgery may delay ovarian cancer return
Disease control OngoingThis is a phase III, multicenter, interventional and randomized study which evaluates the use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) coupled with either Primary Debulking Surgery (PDS) or Interval Debulking Surgery (IDS), in patients with ovarian cancer. This study …
Phase 3 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a friendly welcome cut HIV rates among migrants?
Prevention CompletedMigration is common in rural Africa: in-migrants have higher HIV incidence and prevalence than community residents, but underutilize combined HIV prevention and care services, including voluntary medical male circumcision and antiretroviral therapy, increasing the risks of HIV ac…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Aug 22, 2026 00:00 UTC
-
Off-the-Shelf CAR t cells take on tough lymphomas
Disease control CompletedThe purpose of the ALPHA study is to assess the safety, efficacy, cell kinetics and immunogenicity of ALLO-501 in adults with relapsed or refractory large B-cell lymphoma or follicular lymphoma after a lymphodepletion regimen comprising fludarabine, cyclophosphamide, and ALLO-647…
Phase 1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New combo aims to wipe out hidden myeloma cells after transplant
Disease control CompletedThe purpose of this study is to evaluate conversion rate to minimal residual disease (MRD) negativity following the addition of daratumumab to lenalidomide relative to lenalidomide alone, when administered as maintenance treatment to anti-cluster of differentiation 38 (CD38) trea…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC